4.6 Article

Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx

Sheng-Tao Cheng et al.

Summary: A novel small molecule targeting HBx was identified to combat chronic HBV infection, and it was revealed that NQO1 plays a role in HBV replication by regulating the stability of HBx protein.

JOURNAL OF HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism

Yu Zhang et al.

Summary: Chronic hepatitis B virus (HBV) infection is strongly linked to hepatocellular carcinoma (HCC) development. Genetic alterations and molecular mechanisms, especially HBV-induced metabolic reprogramming, are still underexplored. This study reveals the role of Ct-HBx in HCC progression through downregulation of TXNIP and suggests TXNIP as a potential therapeutic target in treating HCC.

ONCOGENE (2021)

Article Multidisciplinary Sciences

Hepatitis B virus X protein recruits methyltransferases to affect cotranscriptional N6-methyladenosine modification of viral/host RNAs

Geon-Woo Kim et al.

Summary: This study reveals that the viral protein HBV X (HBx) is responsible for the m(6)A modification of viral transcripts, with evidence showing its interaction with m(6)A methyltransferase complexes on the HBV minichromosome. The role of HBx extends to host phosphatase and tensin homolog (PTEN) mRNA, providing insight into how a viral protein recruits RNA methylation machinery to modify RNAs.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis

Hongjuan You et al.

Summary: The study indicated that vimentin expression is increased in HBX-positive hepatoma cells and HBV-related HCC tissues, correlated with HBX. HBX enhances vimentin expression through LASP1 mediated signal pathways, contributing to EMT, proliferation, and migration of HCC cells.

CELL COMMUNICATION AND SIGNALING (2021)

Review Biochemistry & Molecular Biology

The role of N6-methyladenosine modification in the life cycle and disease pathogenesis of hepatitis B and C viruses

Geon-Woo Kim et al.

Summary: Studies have shown that N6-methyladenosine (m(6)A)) modification plays a crucial role in hepatitis virus RNA, affecting viral replication and liver disease pathogenesis. These modifications may also impact m(6)A modifications in host cellular RNA, influencing gene expression and immunity.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Review Oncology

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma

Nanfang Qu et al.

Summary: Liver cancer ranks fifth in terms of incidence worldwide and is the third leading cause of cancer-related deaths. While advancements have been made in treatments such as surgical techniques and immunotherapy, the prognosis for liver cancer patients remains poor. Abnormal expression of m6A-related regulators in HCC has shown potential as diagnostic, prognostic, and therapeutic markers.

FRONTIERS IN ONCOLOGY (2021)

Review Immunology

The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation

Kurt Sartorius et al.

Summary: This review investigates the interplay between chronic hepatitis B infection, the silencing role of miRNA, epigenetic changes, immune system expression, and HBV-HCC pathogenesis. It highlights the influence of HBx-induced epigenetic miRNA pathways in HBV-HCC and demonstrates the complex interplay between HBV infection, epigenetic changes, disease, and immune response. The review suggests that epigenetic changes and miRNA modulation could offer potential therapeutic options in HBV-HCC.

FRONTIERS IN IMMUNOLOGY (2021)

Review Cell Biology

Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma

Enakshi Sivasudhan et al.

Summary: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, imposing a severe economic burden on healthcare systems. The biological influence of epitranscriptomics, particularly m6A RNA methylation, on HCC pathogenesis remains largely unexplored but has immense potential for discovering new therapeutic approaches. Further investigation into the cellular mechanisms underlying HCC development governed by m6A RNA methylation dynamics is warranted.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Immunology

Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes

Liyuan Wang et al.

Summary: ADAR1 interacts with HBV RNA to disrupt host immune recognition through deamination, promoting HBV replication. HBV X protein transcriptionally increases ADAR1 expression to raise the threshold for immune activation, enhancing HBV escape from immune recognition.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Virology

Treatments for HBV: A Glimpse into the Future

Alessandra Bartoli et al.

Summary: Hepatitis B virus is responsible for most chronic liver disease and liver cancer worldwide. New drugs targeting different phases of the virus's lifecycle are currently under investigation for potential future treatments.

VIRUSES-BASEL (2021)

Article Immunology

Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation

Juhee Son et al.

Summary: The HBx protein plays a key role in regulating autophagy in hepatocellular carcinoma (HCC) by inhibiting the BECN1-Bcl-2 complex and enhancing the TRAF6-BECN1-VPS34 complex. These mechanisms contribute to increased cell migration and invasion in liver cancer progression.

IMMUNE NETWORK (2021)

Letter Biochemistry & Molecular Biology

Invasion and metastasis: the elusive hallmark of cancer

Tomer Meirson et al.

ONCOGENE (2020)

Review Biochemistry & Molecular Biology

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis

Mengnuo Chen et al.

MOLECULAR CANCER (2020)

Article Medicine, General & Internal

Oncoprotein LAMTOR5 activates GLUT1 via upregulating NF-κB in liver cancer

Jing Zhou et al.

OPEN MEDICINE (2019)

Article Biotechnology & Applied Microbiology

Antagonism of RIP1 using necrostatin-1 (Nec-1) ameliorated damage and inflammation of HBV X protein (HBx) in human normal hepatocytes

Linsen Xie et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)

Article Gastroenterology & Hepatology

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction

Kazuma Sekiba et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)

Review Genetics & Heredity

Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma

Ping An et al.

FRONTIERS IN GENETICS (2018)

Review Biochemistry & Molecular Biology

Mutant p53 partners in crime

Michael P. Kim et al.

CELL DEATH AND DIFFERENTIATION (2018)

Article Gastroenterology & Hepatology

Identification of FDA-approved drugs that target hepatitis B virus transcription

M. A. A. van de Klundert et al.

JOURNAL OF VIRAL HEPATITIS (2016)

Article Multidisciplinary Sciences

Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor

Adrien Decorsiere et al.

NATURE (2016)

Article Multidisciplinary Sciences

Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma

Pornrat Kongkavitoon et al.

PLOS ONE (2016)

Review Oncology

Hepatitis B virus X protein in liver tumor microenvironment

Sha Fu et al.

TUMOR BIOLOGY (2016)

Article Cell Biology

Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication

Christopher M. Murphy et al.

CELL REPORTS (2016)

Article Gastroenterology & Hepatology

Technical Standards for Hepatitis B Virus X Protein (HBx) Research

Betty L. Slagle et al.

HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?

Vincent Wai-Sun Wong et al.

JOURNAL OF HEPATOLOGY (2015)

Review Pharmacology & Pharmacy

The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease

Mark A. Feitelson et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2014)

Review Biochemical Research Methods

Using proteomics to identify the HBx interactome in hepatitis B virus: how can this inform the clinic?

Na Xie et al.

EXPERT REVIEW OF PROTEOMICS (2014)

Article Multidisciplinary Sciences

Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses

Christian Koeniger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Gastroenterology & Hepatology

Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma

Ashraf Ali et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Immunology

Recognition of human oncogenic viruses by host pattern-recognition receptors

Nelson C. Di Paolo

FRONTIERS IN IMMUNOLOGY (2014)

Article Oncology

C-terminal region of HBx is crucial for mitochondrial DNA damage

Seung-Youn Jung et al.

CANCER LETTERS (2013)

Article Cell Biology

HBx induces HepG-2 cells autophagy through PI3K/Akt-mTOR pathway

Peng Wang et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)

Review Biochemistry & Molecular Biology

MicroRNAs in Stress Signaling and Human Disease

Joshua T. Mendell et al.

Article Biochemical Research Methods

Hepatitis B Virus Encoded X Protein Suppresses Apoptosis by Inhibition of the Caspase-Independent Pathway

Haiying Liu et al.

JOURNAL OF PROTEOME RESEARCH (2012)

Article Biochemistry & Molecular Biology

Structural characterization of an intrinsically unfolded mini-HBX protein from hepatitis B virus

Si-Hyung Lee et al.

MOLECULES AND CELLS (2012)

Article Biochemistry & Molecular Biology

Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer

A. Arzumanyan et al.

ONCOGENE (2012)

Review Virology

Modulation of Apoptotic Signaling by the Hepatitis B Virus X Protein

Siddhartha Rawat et al.

VIRUSES-BASEL (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Biochemistry & Molecular Biology

Hepatitis B Virus X Protein Regulates Hepatic Glucose Homeostasis via Activation of Inducible Nitric Oxide Synthase

Hye-Jun Shin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Gastroenterology & Hepatology

Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway

Wen-Qing Xiang et al.

JOURNAL OF HEPATOLOGY (2011)

Review Oncology

Autophagy: cellular and molecular mechanisms

Danielle Glick et al.

JOURNAL OF PATHOLOGY (2010)

Article Oncology

Inflammation and Liver Cancer New Molecular Links

C. Berasain et al.

STEROID ENZYMES AND CANCER (2009)

Article Biochemistry & Molecular Biology

HBx protein induces EMT through c-Src activation in SMMC-7721 hepatoma cell line

Shi Zhong Yang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Review Oncology

The Double-Edged Sword of Autophagy Modulation in Cancer

Eileen White et al.

CLINICAL CANCER RESEARCH (2009)

Review Oncology

Epithelial-mesenchymal transition in hepatocellular carcinoma

Franziska van Zijl et al.

FUTURE ONCOLOGY (2009)

Review Immunology

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Article Oncology

COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis

Ning-Fang Ma et al.

CLINICAL CANCER RESEARCH (2008)

Review Oncology

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

Mark A. Feitelson et al.

CANCER LETTERS (2007)

Article Pathology

Hepatitis B virus promotes angiopoietin-2 expression in liver tissue -: Role of HBV X protein

Paloma Sanz-Cameno et al.

AMERICAN JOURNAL OF PATHOLOGY (2006)

Review Peripheral Vascular Disease

Angiogenesis in cancer

Naoyo Nishida et al.

VASCULAR HEALTH AND RISK MANAGEMENT (2006)

Review Immunology

The paradox of matrix metalloproteinases in infectious disease

PTG Elkington et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)

Article Gastroenterology & Hepatology

Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3

FL Yu et al.

JOURNAL OF HEPATOLOGY (2005)

Article Medical Laboratory Technology

Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells

XD Zhang et al.

JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2005)

Article Biochemistry & Molecular Biology

Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells

YI Lee et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Review Virology

The enigmatic X gene of hepatitis B virus

MJ Bouchard et al.

JOURNAL OF VIROLOGY (2004)

Article Biochemistry & Molecular Biology

Subcellular localization and transcriptional repressor activity of HBx on p21WAF1/Cip1 promoter is regulated by ERK-mediated phosphorylation

EJ Noh et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Review Cell Biology

Molecular mechanisms of caspase regulation during apoptosis

SJ Riedl et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)

Article Biochemistry & Molecular Biology

Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles

M Forgues et al.

MOLECULAR AND CELLULAR BIOLOGY (2003)

Article Biochemistry & Molecular Biology

Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1 alpha

EJ Moon et al.

FASEB JOURNAL (2003)

Article Biochemistry & Molecular Biology

Expression of hepatitis B virus X (HBx) gene is up-regulated by adriamycin at the post-transcriptional level

CW Yun et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)

Article Oncology

Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma

G Giannelli et al.

INTERNATIONAL JOURNAL OF CANCER (2002)

Review Gastroenterology & Hepatology

Hepatitis B virus X protein: a multifunctional viral regulator

S Murakami

JOURNAL OF GASTROENTEROLOGY (2001)

Article Virology

Subcellular localisation of the X protein in HBV infected hepatocytes

J Hoare et al.

JOURNAL OF MEDICAL VIROLOGY (2001)

Article Biochemistry & Molecular Biology

Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway

M Forgues et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Biochemistry & Molecular Biology

The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade

YI Lee et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Biotechnology & Applied Microbiology

Intracellular localization of the hepatitis B virus HBx protein

F Henkler et al.

JOURNAL OF GENERAL VIROLOGY (2001)

Article Biochemistry & Molecular Biology

Hepatitis B viral X protein overcomes inhibition of E2F1 activity by pRb on the human Rb gene promoter

BH Choi et al.

DNA AND CELL BIOLOGY (2001)

Article Biochemistry & Molecular Biology

Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis

SW Lee et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.

Review Microbiology

Hepatitis B virus biology

C Seeger et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)